Bg pattern

Oculotect 50 mg/ml colirio en solucion

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Oculotect 50 mg/ml colirio en solucion

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Prospect:information for the user

Oculotect 50 mg/ml eye drops solution

Povidone K25

Read this prospect carefully before starting to use this medicine, as it contains important information for you.

Follow exactly the administration instructions of the medicine contained in this prospect or those indicated by your doctor or pharmacist.

  • Keep this prospect, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience adverse effects, consult your doctor or pharmacist, even if they are not listed in this prospect. See section 4.
  • You should consult a doctor if it worsens or does not improve after 3 days.

Contents ofthe prospect:

1.What Oculotect is and for what it is used

2.What you need to know before starting to use Oculotect

3.How to use Oculotect

4.Possible adverse effects

5.Storage of Oculotect

6.Contents of the package and additional information

1. What is Oculotect and what is it used for

Oculotect contains the active ingredient povidone K25. Oculotect is an eye drop for humidifying and lubricating the eyes. It is used to relieve symptoms of dry eye.

You should consult a doctor if it worsens or does not improve after 3 days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Oculotect

Do not use Oculotect

If you are allergic to povidone K25 or any of the other components of this medication (listed in section 6). If you think you may be allergic, do not use this medication without first discussing it with your doctor.

Warnings and precautions

Consult your doctor or pharmacist before starting to use Oculotect eye drops.

If you experience headache, eye pain, changes in vision, eye irritation, persistent redness, or if symptoms worsen or persist, discontinue treatment with Oculotect eye drops and consult your doctor.

Using Oculotect with other medications

Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.

If you need to apply another medication to your eyes in addition to Oculotect, wait at least 5 minutes between applications of each product. Oculotect should always be applied last.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medication. Oculotect can be used during pregnancy and breastfeeding.

Driving and operating machinery

Oculotect may cause blurred vision. If this occurs, wait until the symptom disappears before driving or operating machinery.

Oculotect contains benzalkonium chloride

This medication contains 0.0018 mg of benzalkonium chloride in each drop equivalent to 0.05 mg/ml.

Benzalkonium chloride may be absorbed by soft contact lenses, altering their color. Remove contact lenses before using this medication and wait 15 minutes before reinserting them.

Benzalkonium chloride may cause eye irritation, especially if you have dry eye or other corneal diseases (transparent layer at the front of the eye). Consult your doctor if you experience an unusual sensation, burning, or pain in the eye after using this medication.

3. How to use Oculotect

Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.

The usual dose is one drop in the eye four times a day or as often as necessary.

If a drop falls outside the eye, try again.

If you use more Oculotect than you should,do not expect any adverse effects.

If you are using other eye medications,wait at least 5 minutes between the administration of this eye drop and the other eye medications. Oculotect should be administered last.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Instructions for use

1.Wash your hands.

2.Open the bottle. Do not touch the tip of the dropper after opening the bottle as it may contaminate the solution.

3.Incline your head backward (Fig.1).

4.Pull the lower eyelid down with your finger and hold the bottle with the other hand. The tip of the container should not come into contact with the eye as it may cause eye injury. Press the bottle so that a drop falls into the eye (Fig.2).

5.Close your eyes and press with a finger the inner angle of the eye for 1-2 minutes approximately. This prevents the drop from flowing down the tear duct into the throat, so that most of the drop remains in the eye (Fig.3). If necessary, repeat steps 3 to 5 with the other eye.

6.Close the bottle after use.

Fig.1Fig.2Fig.3

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Adverse Effects

Like all medications, this medication may produce adverse effects, although not all people will experience them.

The following adverse effects have been reported:

Frequent (may affect up to 1 in 10 people)

-Mild and transient sensation of burning or itching in the eye (eyes)

Very Rare (may affect up to 1 in 10,000 people)

-Irritation

-Allergic reaction

Unknown Frequency(cannot be estimated from available data)

-Blurred vision, eye pain, eye itching, eye redness.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Preservation of Oculotect

Keep this medication out of the sight and reach of children.

Do not store at a temperature above 25°C.

Store the container in the outer packaging to protect it from light.

The bottle is not sterile, but its contents are sterile until the bottle is opened.

After the first opening of the bottle, the eye drops can only be stored for 4 weeks.

Do not use this medication after the expiration date that appears on the container after CAD. The expiration date is the last day of the month indicated.

Medicines should not be disposed of through drains or in the trash. Dispose of containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.

6. Content of the container and additional information

Composition of Oculotect

The active principle ispovidone K25. Each ml contains 50 mg ofpovidone K25.

The other components are benzalkonium chloride as a preservative, boric acid, calcium chloride, potassium chloride, magnesium chloride, sodium chloride, sodium lactate, sodium hydroxide to adjust pH, and water for injectable preparations.

Appearance of the product and content of the container

Oculotect is a transparent, slightly yellowish aqueous solution. The solution is presented in a container that contains a 10 ml vial.

Holder of the marketing authorization andresponsible for manufacturing

Holder of the marketing authorization

Alcon Healthcare, S.A.

World Trade Center Almeda Park

Plaça de la Pau s/n, Edificio 6, planta 3

08940 - Cornellà de Llobregat (Barcelona)

Responsible for manufacturing

EXCELVISION

Rue de la Lombardière, BP 131

Annonay Cedex, F-07100-France

or

Alcon Couvreur N.V.

Rijksweg 14

B-2870 Puurs

Belgium

or

Alcon Laboratories Belgium

Lichterveld 3

2870 Puurs-Sint-Amands

Belgium

This medicine is authorized in the member states of the European Economic Area with the following names:

DenmarkOculac (MDU)

FinlandOculac (MDU)

PortugalOculotect (fluid)

SpainOculotect 50 mg/ml eye drops in solution

SwedenOculac

Last review date of this leaflet: November 2020.

The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es

Online doctors for Oculotect 50 mg/ml colirio en solucion

Discuss questions about Oculotect 50 mg/ml colirio en solucion, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for Oculotect 50 mg/ml colirio en solucion?
Oculotect 50 mg/ml colirio en solucion does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in Oculotect 50 mg/ml colirio en solucion?
The active ingredient in Oculotect 50 mg/ml colirio en solucion is artificial tears and other indifferent preparations. This information helps identify medicines with the same composition but different brand names.
How much does Oculotect 50 mg/ml colirio en solucion cost in pharmacies?
The average pharmacy price for Oculotect 50 mg/ml colirio en solucion is around 8.13 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures Oculotect 50 mg/ml colirio en solucion?
Oculotect 50 mg/ml colirio en solucion is manufactured by Alcon Healthcare S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of Oculotect 50 mg/ml colirio en solucion online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Oculotect 50 mg/ml colirio en solucion is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to Oculotect 50 mg/ml colirio en solucion?
Other medicines with the same active substance (artificial tears and other indifferent preparations) include ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media